Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neuberger Berman High Yield Strategies Fund has the GF Score of 44, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Neuberger Berman High Yield Strategies Fund GF Score Related Terms
NHS vs NRO, TPVG, OPP: GF Score Comparison
For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuberger Berman High Yield Strategies Fund GF Score vs Asset Management Industry
Neuberger Berman High Yield Strategies Fund (NHS) has a GF Score of 44 as of Jul. 16, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. This is near median its historical median of 47.00. Over the past decade, Neuberger Berman High Yield Strategies Fund's GF Score has ranged from 28.00 to 61.00.
Is Neuberger Berman High Yield Strategies Fund's GF Score too high?
Neuberger Berman High Yield Strategies Fund's current GF Score of 44 is near median its 10-year median of 47.00. Over the past 10 years, this metric has ranged from a low of 28.00 to a high of 61.00. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's GF Score compare to NRO and TPVG?
Neuberger Berman High Yield Strategies Fund's GF Score of 44 can be compared against companies in the Asset Management industry. Historically, Neuberger Berman High Yield Strategies Fund's own GF Score has ranged from 28.00 to 61.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for an Asset Management company?
A good GF Score depends on the Asset Management industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. Neuberger Berman High Yield Strategies Fund's current GF Score is 44, which is near median its own 10-year median of 47.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.16 — trading 14.8% below its estimated fair value. The current GF Score is 44, which is near median its 10-year median of 47.00. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current GF Score is 44 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued.
The current stock price of $6.16 is trading 14.8% below its estimated GF Value™ of $7.23.
GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.
Key valuation signals for NHS:
GF Score: 44 (near median its 10-year median of 47.00)
GF Value™: $7.23 vs. price of $6.16 (14.8% below fair value)
No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuberger Berman High Yield Strategies Fund Business Description
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score
Get the complete analysis for NHS
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHS has been successfully added to your 
